3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Skin Neoplasms
1
Recurrence
1
Neoplasms
1
Multiple Sclerosis, Relapsing-Remitting
1
Multiple Sclerosis
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Gliosarcoma
1
Glioblastoma
1
Carcinoma, Basal Cell
1
Interventions
fludarabine
2
Fingolimod Hydrochloride
2
Cyclophosphamide
2
Blood Specimen Collection
2
teriflunomide
1
gadobutrol
1
gadobenic acid
1
Surveys and Questionnaires
1
Specimen Handling
1
Respiratory Therapy
1
Registries
1
Platelet Transfusion
1
Phlebotomy
1
OM 89
1
Nivolumab
1
Natalizumab
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Interferon beta-1a
1
Gadolinium DTPA
1
Fish Oils
1
Exergaming
1
Dimethyl Fumarate
1
Dietary Fiber
1
Data Collection
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Multiple Sclerosis
×
Dimethyl Fumarate
×
Clear all
NCT06705608
2024-11-26
MS; FTY720
University of British Columbia
Completed
4,000 enrolled